Chargement en cours...
A potent tetravalent T-cell–engaging bispecific antibody against CD33 in acute myeloid leukemia
Acute myeloid leukemia (AML), the most common acute leukemia in adults and the second most common cancer in children, is still a lethal disease in the majority of patients, but immunologic approaches have improved outcome. Bispecific antibodies (BsAbs) are novel immunotherapeutics that can redirect...
Enregistré dans:
| Publié dans: | Blood Adv |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998923/ https://ncbi.nlm.nih.gov/pubmed/29858209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017014373 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|